UPDATE: FDA Panel Backs Saphris To Treat Schizophrenia,Bipolar - CNN Money
WASHINGTON -(Dow Jones)- The Food and Drug Administration panel Thursday backed asenapine, a proposed Schering-Plough Corp. (SGP) drug, to treat schizophrenia and bipolar disorder. The panel unanimously said asenapine, which would be sold under the …